Methyl 1-[3-chloro-5-(trifluoromethyl)-2-pyridinyl]-4-piperidinecarboxylate, 95.0%, 1g

Microliter syringe for HPLC, 500 µl, 1 piece

2,4-Bis(trifluoromethyl)aniline, 97.0%, 1g

N,N'-BIS[3-(2-METHOXYPHENYL)-2-HYDROXYBENZYL](1R,2R)-1,2-CYCLOHEXANEDIAMINE, 95%, 1g

N,3-Dimethylbutan-1-amine hydrochloride, 97%, 5g

4-Oxazolecarboxamide, 2-(2-chloro-6-fluorophenyl)-5-[[4-(4-morpholinylcarbonyl)phenyl]amino]-, 250mg

Methyl 2-[(2-ethoxyethyl)sulfanyl]acetate, 1g

2-methylimidazo[1,2-a]pyridine-3-carbonyl chloride hydrochloride, 95.0%, 250mg

((4S,5S)-2,2-Dimethyl-1,3-dioxolane-4,5-diyl)dimethanol, 95.0%, 1g

1,3-Di(1H-pyrazol-4-yl)benzene, 98%, 5g

2-(4-Bromo-2-methylphenyl)acetonitrile, 95.0%, 1g

BOC-D-LEU-OSU, 97.0%, 1g

4-(Bromomethyl)benzo[d]thiazole, 95.0%, 5g